Leonteq Securities’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Leonteq Securities's EW Position: Q3 2026 in Review
Leonteq Securities increased its Edwards Lifesciences (EW) stake by 69% in Q3 2026, buying an estimated $33.7K and bringing the position to 928 shares worth $80.1K. The position accounts for ﹤0.01% of the portfolio, ranked #702.
Leonteq Securities first reported a position in EW in Q4 2020 and has held it in 24 quarters since. The position peaked at $2.85M in Q4 2022. 1,339 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Leonteq Securities held 928 shares of Edwards Lifesciences worth $80.1K as of Q3 2026.
- Leonteq Securities bought 379 Edwards Lifesciences shares in Q3 2026, an estimated $33.7K.
- Edwards Lifesciences made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #702 holding.
- Leonteq Securities first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 24 quarters since.
- Leonteq Securities's Edwards Lifesciences position peaked at $2.85M in Q4 2022.
- 1,339 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.